Dilated Cardiomyopathy as a Rare Presentation of Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report

Vipulkumar V Gandhi1, Komal Chopra2

  • 1Imperial Multispecialty Hospital, Chikhali, Pune, India.

Insights

Multisystem inflammatory syndrome in children (MIS-C), a rare COVID-19 complication, can lead to dilated cardiomyopathy. Early detection and management are crucial for pediatric patients with MIS-C to address potential cardiac issues.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious post-infectious sequela of SARS-CoV-2 infection.
  • Cardiovascular involvement is a recognized, though infrequent, manifestation of MIS-C.
  • Dilated cardiomyopathy represents a significant cardiac complication requiring careful monitoring.

Observation:

  • A pediatric case of MIS-C is presented with a focus on its cardiovascular sequelae.
  • The patient developed dilated cardiomyopathy as a notable complication during the course of MIS-C.
  • Detailed clinical observations of the cardiac manifestation are documented.

Findings:

  • The case highlights the potential for severe cardiac dysfunction, specifically dilated cardiomyopathy, in children with MIS-C.
  • This underscores the heterogeneity of MIS-C presentations and its impact on the cardiovascular system.
  • Diagnostic and therapeutic challenges associated with MIS-C-induced cardiomyopathy are implicitly discussed.

Implications:

  • Enhances understanding of rare cardiovascular complications associated with MIS-C.
  • Emphasizes the critical need for vigilant cardiac surveillance in pediatric patients with MIS-C.
  • Informs clinical practice regarding the prompt recognition and management of MIS-C-related cardiac dysfunction.